Company page

Heidelberg Pharma Ag

Heidelberg Pharma AG is a public company listed on the German market under the ticker HPHA. The company has a market capitalization of approximately €136.5 million. Heidelberg Pharma focuses on developing innovative therapies, particularly in the field of cancer treatment.

HPHA:XETRUpdated September 11, 2026
Heidelberg Pharma Ag logo
Ticker
HPHA:XETR
Asset type
Stock
Market cap
$133.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
XETR
Currency
EUR